Dermtech Stock Net Income
| DMTK Stock | USD 0.59 0 0.17% |
DermTech fundamentals help investors to digest information that contributes to DermTech's financial success or failures. It also enables traders to predict the movement of DermTech Stock. The fundamental analysis module provides a way to measure DermTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DermTech stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -100.9 M | -95.8 M | |
| Net Loss | -105 M | -99.8 M | |
| Net Loss | -100.9 M | -95.8 M | |
| Net Loss | (3.09) | (3.25) | |
| Net Income Per E B T | 1.12 | 1.11 |
DermTech | Net Income |
DermTech Company Net Income Analysis
DermTech's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current DermTech Net Income | (100.89 M) |
Most of DermTech's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DermTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
DermTech Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for DermTech is extremely important. It helps to project a fair market value of DermTech Stock properly, considering its historical fundamentals such as Net Income. Since DermTech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DermTech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DermTech's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
DermTech Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, DermTech reported net income of (100.89 Million). This is 129.56% lower than that of the Biotechnology sector and 158.28% lower than that of the Health Care industry. The net income for all United States stocks is 117.67% higher than that of the company.
DermTech Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DermTech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DermTech could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics of similar companies.DermTech is currently under evaluation in net income category among related companies.
DermTech Institutional Holders
Institutional Holdings refers to the ownership stake in DermTech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of DermTech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing DermTech's value.| Shares | Susquehanna International Group, Llp | 2023-12-31 | 85.7 K | Woodmont Investment Counsel Llc | 2023-12-31 | 84.2 K | Northern Trust Corp | 2023-12-31 | 77.5 K | Bank Of New York Mellon Corp | 2023-12-31 | 75.2 K | Jane Street Group, Llc | 2023-12-31 | 74.8 K | State Treasurer State Of Michigan | 2023-12-31 | 60 K | Advisor Group Holdings, Inc. | 2023-12-31 | 59.3 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 57.6 K | Virtu Financial Llc | 2023-12-31 | 55.2 K | Vanguard Group Inc | 2023-12-31 | 1.4 M | Blackrock Inc | 2023-12-31 | 434.9 K |
DermTech Fundamentals
| Return On Equity | -1.06 | ||||
| Return On Asset | -0.38 | ||||
| Operating Margin | (5.03) % | ||||
| Current Valuation | 19.8 M | ||||
| Shares Outstanding | 34.62 M | ||||
| Shares Owned By Insiders | 4.24 % | ||||
| Shares Owned By Institutions | 21.26 % | ||||
| Number Of Shares Shorted | 3.16 M | ||||
| Price To Earning | (139.70) X | ||||
| Price To Book | 0.38 X | ||||
| Price To Sales | 1.41 X | ||||
| Revenue | 15.3 M | ||||
| Gross Profit | 647 K | ||||
| EBITDA | (97.89 M) | ||||
| Net Income | (100.89 M) | ||||
| Cash And Equivalents | 173.79 M | ||||
| Cash Per Share | 5.78 X | ||||
| Total Debt | 54.39 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 12.19 X | ||||
| Book Value Per Share | 1.66 X | ||||
| Cash Flow From Operations | (76.98 M) | ||||
| Short Ratio | 6.32 X | ||||
| Earnings Per Share | (3.09) X | ||||
| Target Price | 2.75 | ||||
| Number Of Employees | 206 | ||||
| Beta | 2.56 | ||||
| Market Capitalization | 21.27 M | ||||
| Total Asset | 121.93 M | ||||
| Retained Earnings | (423.94 M) | ||||
| Working Capital | 48.3 M | ||||
| Current Asset | 140.61 K | ||||
| Current Liabilities | 446.54 K | ||||
| Net Asset | 121.93 M |
About DermTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DermTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DermTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DermTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DermTech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DermTech's short interest history, or implied volatility extrapolated from DermTech options trading.
Pair Trading with DermTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DermTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DermTech will appreciate offsetting losses from the drop in the long position's value.Moving against DermTech Stock
| 0.8 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.67 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.57 | MRSN | Mersana Therapeutics Downward Rally | PairCorr |
| 0.55 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.53 | ZNTL | Zentalis PharmaceuticalsL Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to DermTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DermTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DermTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DermTech to buy it.
The correlation of DermTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DermTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DermTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DermTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out DermTech Piotroski F Score and DermTech Altman Z Score analysis. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 0.469 | Quarterly Revenue Growth 0.311 | Return On Assets (0.38) | Return On Equity (1.06) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.